Results for: NCCAM
The Ethics of “CAM” Trials: Gonzo (Part IV)
A Review; then Back to the Gonzalez Regimen† Part I of this blog introduced the topic of the “Gonzalez regimen” for treating cancer: “Intensive Pancreatic Proteolytic Enzyme Therapy With Ancillary Nutritional Support” and “detoxification” with twice daily coffee enemas, daily “skin brushing,” “a complete liver flush and a clean sweep and purge on a rotating basis each month,” and more. The topic...
Borderlines in research
This is a slight departure from the usual fare of pseudoscience, but a matter that should concern us because of the vulnerability this matter confers on medicine – the borderline practices of major medical centers. The article can be viewed here. Several days ago the San Francisco Chronicle printed a second article about the plight of a 37 year old woman (EP)...
Studying Placebo Effects
Measuring placebo effects (often misleadingly referred to as the placebo effect – singular) is a part of standard clinical trial design, because they need to be distinguished from the physiological effects of the treatment under study. Rarely, however, are placebo effects the actual target being measured, but such is the case with a new study published in the most recent edition of...
The Weekly Waluation of the Weasel Words of Woo #3
Last Week’s Entry: Everyone’s a Winner! The resounding total of 4 “translations” for the second W^5 entry might have been trying to tell me something…nah! I gotta say that each of the four nailed the central point: the esteemed Institute of Medicine (IOM), a subset of the esteemed National Academy of Sciences, has decided that it’s just fine—no, it is “important” and...
The Ethics of “CAM” Trials: Gonzo (Part II)
Laetrile and the Politics of NIH-Sponsored trials of “Alternative Cancer Treatments” Part I of this blog ended by asking how, in light of the implausible and arduous nature of the “Gonzalez regimen” for cancer of the pancreas, and the unconvincing “best case series,” the NIH could ever have decided to fund a trial of it.† This entry will begin to answer that question. In so...
Charlie Woo TV
Some of us received the announcement a week ago of the Bravewell Collaborative’s planned conference on “Integrative Medicine” co-sponsored with the National Academies’ Institute of Medicine, to take place in February, 2009. (Note: I like to cap slogans and commercial trademarks and such and enclose them in quotation marks. Especially when the terms have no consensus meaning or are intended to obscure...
The Ethics of “CAM” Trials: Gonzo (Part I)
Blogger’s note: This blog, which is rough going in places, will be presented in either 2 or 3 parts (I won’t know which until next week). I’ll post a part each week until it is complete, but due to overwhelming popular demand I promise to maintain the every-other-week posting of the far more amusing Weekly Waluation of the Weasel Words of Woo/2. Introduction On Feb. 25,...
My Woo: A Confession
It’s a case of mind over matter. I have no mind but it doesn’t seem to matter. — George Burns I should be working on my taxes. Instead, I’ll dwell on the other, more pleasant, inevitability. Its been a bad couple of months for death. Everyone dies, and people often die of infection, but the flu season has been busy and with...
Where Are We Going?
Where is it all headed? Medicine on another threshold. Allow me to present several previously unconnected news articles that illuminate the serious problem we face in today’s increasingly scientifically rootless world. Who are scientific medicine’s friends; on whom can we rely for support of reason and common sense, unbiased approaches to funding, unbiased efficacy evaluation, fair law enforcement, and a return to...
The ultimate in “integrative medicine”: Integrating the unscientific into the medical school curriculum
For the second week in a row I find myself throwing out the original post that I had planned on doing in favor of a different topic. The reason this week is, quite simply, having read Dr. Atwood’s excellent two part post Misleading Language: The Common Currency of “CAM” Characterizations (Part I; Part II). I don’t at this time intend to expand...